Latest News

Home testing devices could monitor epilepsy, drug levels, reduce clinical visits

Medications remain the mainstay of epilepsy treatment, and to date there are no FDA-approved devices that provide an accurate means of detection for generalized tonic-clonic seizures (GTCS), or convulsions, during activities of daily living. Two new studies provide data that warrants the development of non-invasive devices with the capability to signal the onset of an epileptic seizure and could be crucial to optimal patient dosing.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Image-guided treatment shown to break the migraine cycle

  • Virtual patient: Avatar shows emotions as he talks to med students

  • Psychology of food choice: Challenging the status quo

  • Can money buy happiness? The relationship between money and well-being

  • Finding psychological insights through social media

  • How does the human brain tackle problems it did not evolve to solve?

  • Patient perceptions of physician compassion measured

  • Reviving drugs with anti-stroke potential, minus side effects

  • Intimate partners with low self-esteem stay in unhappy relationships

  • New compounds protect nervous system from the structural damage characteristic of multiple sclerosis

  •